Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Author Title [ Type] Year Filters: Author is Polyzos, Stergios A [Clear All Filters]
Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012). Subendothelial carotid hematoma after fine-needle aspiration biopsy of a solitary thyroid nodule..
J Ultrasound Med. 27(10), 1517-20.
(2008). Spironolactone revisited..
J Clin Hypertens (Greenwich). 13(10), 783-4.
(2011). Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease..
Eur J Pharmacol. 907, 174272.
(2021). Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study..
Clin Nutr. 41(6), 1281-1289.
(2022). Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead..
Metabolism. 78, A4-A9.
(2018).
(2023). Similar late effects of a 7-week orthodox religious fasting and a time restricted eating pattern on anthropometric and metabolic profiles of overweight adults..
Int J Food Sci Nutr. 1-11.
(2020). Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease..
Hormones (Athens). 12(3), 405-16.
(2013). Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease..
Int J Food Sci Nutr. 63(6), 659-66.
(2012). Serum visfatin in nonalcoholic fatty liver disease..
Ann Hepatol. 13(1), 150-1.
(2013). Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum..
Cytokine. 61(1), 127-32.
(2013). Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis..
Metabolism. 60(3), 313-26.
(2011). Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules..
J Cancer Res Clin Oncol. 134(9), 953-60.
(2008). Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis..
J Clin Endocrinol Metab. 97(4), E618-21.
(2012). Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study..
J Clin Endocrinol Metab. 104(2), 349-358.
(2019). Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?.
Mol Ther. 20(1), 6-7.
(2012). Serum homocysteine levels in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 11(1), 68-76.
(2012). Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid..
J Bone Miner Metab. 28(3), 314-9.
(2010). SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR..
Endocr Pract. 22(1), 68-75.
(2016). Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer..
Hormones (Athens).
(2022). Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease..
Exp Clin Endocrinol Diabetes.
(2019). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020). Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone..
J Bone Miner Metab. 26(6), 635-41.
(2008). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018).